WLNS Lansing on MSN

6 News at 6 p.m.: The headlines - November 2, 2026

6 News at 6 p.m.: The Headlines - November 2, 2026 ...

Google DeepMind Is Trying To Solve A Huge Problem In Healthcare: Antimicrobial Resistance

Antimicrobial resistance (AMR), also known generally as “drug resistance,” is a common yet concerning aspect of healthcare.

Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs

Isomorphic Labs, the brainchild of Nobel Laureate Demis Hassabis, has an ambitious mission even by the standards of AI labs: ...
kingy.ai

Cascade: How a 100-Million-Cell AI Project Could Transform Drug Discovery

Discover how Cascade AI's 100-million-cell project could transform drug discovery through immune research and advanced ...

The human surfaceome: AI flags potential cell surface drug targets overlooked by major databases

More than 65% of approved medicines work by binding to proteins on the surface of human cells. Yet scientists developing new ...
BIOENGINEER

Computational screen of 407,270 natural compounds yields four predicted dengue polymerase inhibitors

A purely computational study screened 407,270 natural compounds against the dengue virus RNA-dependent RNA polymerase and ...
BIOENGINEER

MRI and Open-Source Python Tool Reveal How Subcutaneous Drug Depots Really Form

An ex vivo porcine skin model combined with MRI and open-source computational analysis quantified subcutaneous drug depots ...
Tech Times

Intel Pays $2.3B for Classiq, Claiming Quantum Software Stack Before Hardware Race Ends

Intel Classiq acquisition marks the largest deal in quantum computing history: Intel pays $2.3 billion to own the software ...
Crypto Briefing

Anthropic partners with six companies to push Claude into drug discovery

Anthropic reveals Claude AI partnerships with six companies, including BMS and Generate Biomedicines, to accelerate drug ...
Unite.AI

Anthropic Reports Early Drug Development Progress With Claude

Anthropic on October 27, 2026 published a progress update on its life sciences work, reporting early results from research ...

Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets

Pythia Labs, a biotechnology company building frontier AI models for therapeutic discovery, today announced its launch alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative ...